Achieve Antimicrobial Stewardship Through Improved Diagnostic Safety
Align Your Sepsis Protocol and Drive Antibiotic Stewardship with the Steripath® Platform
Reducing blood culture contamination, which contributes to a misdiagnosis of sepsis and unnecessary administration of antibiotics like Vancomycin, proves to be one of the most effective methods in preventing multi-drug resistant organisms (MDROs) and avoiding antibiotic-related infections like Clostridioides difficile Infection (CDI).
Steripath® Micro is FDA 510(k)-cleared to specifically reduce blood culture contamination, initiating a ripple effect of quality improvement and positive outcomes for patients and hospitals nationwide. The use of the Steripath Platform has been shown to reduce Vancomycin days of therapy (DOT) by as much as 31%.31
Only Four Ways to Stop Antibiotic Resistance
Diagnostic Stewardship with the Steripath Platform can help achieve three of these four ways to stop resistance.
Prevent an infection from happening (CDI)
Prevent its spread (E-LOS)
Improve antibiotic use (prevent unnecessary/inappropriate)
Develop new drugs and diagnostic tests.
Drive Antibiotic Stewardship
Blood culture results play a critical role in determining if antibiotic treatment can be de-
escalated for patients in the sepsis protocol. Treatment is typically continued for patients with positive blood cultures, even when contamination is suspected. Reducing false-positive blood culture results can guide appropriate treatment and dramatically reduce unnecessary antibiotic treatment.
Time to de-escalation
Increased confidence in blood culture results to better guide patient treatment
Hospital-onset antibiotic resistance
Reduce prolonged use of unnecessary broad-spectrum antibiotics
Antibiotic cost per admission
Cut costs associated with unnecessary antibiotic treatment
We’re on a mission to improve the diagnostic accuracy and timeliness of sepsis test results.